CareDx, Inc.
1 Tower Pl, 9th Floor
South San Francisco, CA 94080
United States
326 articles about CareDx, Inc.
-
XDx, Inc. (JOBS) Completes $14.4 Million Series G Financing, After Pulling IPO
8/5/2009
-
XDx, Inc. Selected to Present at InsideVenture’s Debut Investor Conference March 25-26, Santa Barbara, California
3/23/2009
-
XDx, Inc. and Bristol-Myers Squibb Enter into Pharmacogenomics Collaboration
1/9/2009
-
XDx Announces Strategic Restructuring; Reduces 25 Positions
11/24/2008
-
XDx to Present at the 2008 In Vitro Diagnostic Regulatory and Reimbursement Conference
11/18/2008
-
XDx To Present At The Third Annual JMP Securities Healthcare Focus Conference
10/6/2008
-
XDx Inc. Cancels IPO
9/8/2008
-
XDx's AlloMap(R) Gene Expression Test Cleared by FDA
8/27/2008
-
XDx, Inc. Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
5/20/2008
-
XDx, Inc. Files Reexamination Request for Source MDx Patent
2/15/2008
-
XDx, Inc. Files with US SEC for $86.25 Million IPO
10/24/2007
-
XDx Selects Ingenuity Systems IPA 5.0 for Pathways Solution
7/10/2007
-
XDx Presents Recent Success with AlloMap(R) Molecular Expression Testing to International Transplantation Community
4/26/2007
-
XDx Inc. And University of Minnesota Establish Lupus Collaboration
2/20/2007
-
BIO To Present At XDx CEO & Investor Conference
2/9/2007
-
XDx Release: Independent Clinical Data Confirms Accuracy Of Gene Expression Test For Heart Transplant Patients
1/24/2007
-
XDx Announces Appointment Of Dr. Mitchell Nelles To Vice President R&D, Technical Operations
1/2/2007
-
Gene Expression Test From XDx Now Indicated For Earlier Use And Prediction Of Acute Cellular Rejection
10/31/2006
-
XDx Selects Franek Technologies To Protect $900,000 In Instrumentation Enabling Revolutionary Post-Cardiac Transplant Rejection Monitoring
10/30/2006
-
XDx Announces Appointment Of Dr. James Yee As Chief Medical Officer
8/16/2006